Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Cancer Discovery|October 11, 2011
PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine networkHaoqiang Ying, Kutlu G Elpek, Anant Vinjamoori, et al.Nature|August 15, 2014
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial functionAndrea Viale, Piergiorgio Pettazzoni, Costas A Lyssiotis, et al.Blood Cancer Discovery|August 4, 2022
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed SideroblastsVera Adema, Feiyang Ma, Rashmi Kanagal-Shamanna, et al.Leukemia|February 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemiaSamarpana Chakraborty, Claudia Morganti, Kimberly Zaldana, et al.Nature|February 11, 2011
Telomere dysfunction induces metabolic and mitochondrial compromiseErgün Sahin, Simona Colla, Marc Liesa, et al.Nature Communications|June 4, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AMLMatteo Marchesini, Andrea Gherli, Elisa Simoncini, et al.Biorxiv : the Preprint Server for Biology|March 23, 2026
Aberrant oxidative metabolism selects for TET2 -deficient hematopoietic stem and progenitor cellsKatia E Niño, Vera Adema, Alyx E Gray, et al.Nature Medicine|March 4, 2022
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapyIrene Ganan-Gomez, Hui Yang, Feiyang Ma, et al.Cell Reports|November 14, 2015
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch PointRachel B Darman, Michael Seiler, Anant A Agrawal, et al.Biorxiv : the Preprint Server for Biology|June 3, 2024
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.Pageof 10